| 2022-12-27 | +70.1% | news | Seeking Alpha | Minerva Surgical stock rises after Accelmed takes controlling stake |
| 2022-12-27 | +70.1% | news | GlobeNewswire | Minerva Surgical Announces $30 Million Private Placement of Common Stock Led by Accelmed Partners - GlobeNewswire |
| 2022-12-28 | +46.5% | executive | Seeking Alpha | Minerva Surgical appoints Todd Usen to succeed David Clapper as CEO |
| 2022-12-28 | +46.5% | executive | SEC EDGAR | UTRS 8-K: 5.02, 8.01 (SEC Filing) |
| 2022-12-28 | +46.5% | M&A | SEC EDGAR | UTRS 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-12-18 | -44.4% | news | InvestorPlace | Why Is Minerva Surgical (UTRS) Stock Down 50% Today? - InvestorPlace |
| 2023-12-18 | -44.4% | M&A | InvestorPlace | ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement - InvestorPlace |
| 2023-05-24 | +38.6% | news | InvestorPlace | Why Is Minerva Surgical (UTRS) Stock Up 229% Today? - InvestorPlace |
| 2023-05-24 | +38.6% | news | Securities.io | Top 5 Women’s Health Stock (April 2026) - Securities.io |
| 2023-11-13 | -32.8% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2022-11-15 | -25.8% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) Q3 2022 Earnings Call Transcript |
| 2023-11-14 | -21.4% | earnings | Seeking Alpha | Minerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93M |
| 2022-05-11 | -20.9% | earnings | Seeking Alpha | GAAP EPS of -$0.38 misses by $0.07, revenue of $10.9M beats by $0.14M |
| 2022-05-11 | -20.9% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2022-05-11 | -20.9% | news | GlobeNewswire | Minerva Surgical Reports First Quarter 2022 Financial Results - GlobeNewswire |
| 2022-08-10 | -20.3% | earnings | Seeking Alpha | Minerva downgraded at JPMorgan citing lowered guidance |
| 2022-11-14 | -18.2% | earnings | Seeking Alpha | GAAP EPS of -$0.40 misses by $0.12, revenue of $12.6M in-line |
| 2023-03-21 | -16.1% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) Q4 2022 Earnings Call Transcript |
| 2023-03-21 | -16.1% | earnings | Seeking Alpha | Minerva Surgical GAAP EPS of -$1.18 misses by $0.05, revenue of $50.29M misses by $0.43M |
| 2023-03-21 | -16.1% | earnings | SEC EDGAR | UTRS 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-08-09 | -14.3% | earnings | Seeking Alpha | GAAP EPS of -$0.20 beats by $0.14, revenue of $12.97M misses by $0.44M |
| 2022-08-09 | -14.3% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2023-11-02 | -13.9% | news | SEC EDGAR | UTRS 8-K: 8.01 (SEC Filing) |
| 2022-05-15 | +11.4% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) CEO David Clapper on Q1 2022 Results - Earnings Call Transcript |
| 2023-09-28 | -8.9% | M&A | SEC EDGAR | UTRS 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2023-05-02 | -8.2% | earnings | Seeking Alpha | Minerva Surgical reports Q1 results, provides FY 2023 revenue guidance |
| 2023-05-02 | -8.2% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2022-08-13 | -7.9% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) CEO Dave Clapper on Q2 2022 Results - Earnings Call Transcript |
| 2022-07-21 | +7.7% | executive | SEC EDGAR | UTRS 8-K: 5.02 and (SEC Filing) |
| 2023-01-17 | -7.0% | executive | SEC EDGAR | UTRS 8-K: 5.02 (SEC Filing) |
| 2022-11-16 | -6.7% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2023-05-03 | -5.4% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) Q1 2023 Earnings Call Transcript |
| 2021-12-03 | -5.3% | earnings | Seeking Alpha | Minerva tops Q3 sales estimates; Piper 'strongly' encourages buying stock after Q3 results |
| 2022-01-11 | +4.3% | earnings | Seeking Alpha | Minerva Surgical reports preliminary Q4 and FY21 revenue |
| 2023-03-23 | -4.1% | executive | MassDevice | Minerva Surgical names Kaile Zagger chief commercial officer - MassDevice |
| 2022-01-31 | +3.4% | news | SEC EDGAR | UTRS 8-K: 8.01 and (SEC Filing) |
| 2022-08-03 | -3.3% | M&A | SEC EDGAR | UTRS 8-K: 1.01 and 2.03 (SEC Filing) |
| 2021-12-02 | -3.0% | earnings | Seeking Alpha | Minerva Surgical EPS misses by $0.72, beats on revenue |
| 2021-12-02 | -3.0% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2022-01-13 | +2.9% | news | SEC EDGAR | UTRS 8-K: 8.01 (SEC Filing) |
| 2022-03-22 | -2.9% | earnings | SEC EDGAR | UTRS 8-K: 2.02 (SEC Filing) |
| 2021-11-02 | -2.9% | news | Seeking Alpha | Minerva Surgical - Uterine Play For Sale |
| 2023-03-07 | -2.7% | executive | SEC EDGAR | UTRS 8-K: 5.02 (SEC Filing) |
| 2023-02-09 | +2.5% | M&A | SEC EDGAR | UTRS 8-K: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 8.01 (SEC Filing) |
| 2023-02-09 | +2.5% | news | MassDevice | Minerva Surgical closes $30M financing, has new controlling stockholder - MassDevice |
| 2023-07-07 | -2.4% | executive | SEC EDGAR | UTRS 8-K: 5.02 and 8.01 (SEC Filing) |
| 2022-02-25 | -1.6% | news | StockInvest.us | Minerva Surgical Stock Price Forecast. Should You Buy UTRS? - StockInvest.us |
| 2023-08-07 | -1.3% | earnings | Seeking Alpha | Minerva Surgical, Inc. (UTRS) Q2 2023 Earnings Call Transcript |
| 2023-10-13 | -0.9% | executive | SEC EDGAR | UTRS 8-K: 5.02 (SEC Filing) |
| 2022-03-08 | +0.7% | earnings | Seeking Alpha | Minerva Surgical reports Q4 results |
| 2022-03-08 | +0.7% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2023-08-02 | +0.4% | earnings | Seeking Alpha | Minerva Surgical GAAP EPS of -$0.05 beats by $0.04, revenue of $13.4M misses by $0.52M |
| 2023-08-02 | +0.4% | earnings | SEC EDGAR | UTRS 8-K: 2.02 and (SEC Filing) |
| 2021-10-22 | — | news | Seeking Alpha | Minerva Surgical drops over 25% on trading debut |
| 2021-10-22 | — | news | Seeking Alpha | Minerva Surgical prices IPO at $12, below estimated range |